Current clinical evidence is insufficient to support HMME-PDT as the first choice of treatment for young children with port wine birthmarks. - Gao C; Nguyen V; Hochman ML; Gao L; Chen EH; Friedman HI; Nelson JS; Tan W (Lasers in surgery and medicine, 2024)